UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 223

Sortiert nach

Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.326-331

2014

Volltextzugriff (PDF)

Role of radiotherapy in metastatic non-small cell lung cancer

Frontiers in oncology, 2014-01, Vol.4, p.229-229

Faria, Sergio L

2014

Volltextzugriff (PDF)

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332

2016

Volltextzugriff (PDF)

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

The Lancet (British edition), 2022-05, Vol.399 (10338), p.1886-1901

2022

Volltextzugriff (PDF)

Impact of FDG-PET/CT on Radiotherapy Volume Delineation in Non–Small-Cell Lung Cancer and Correlation of Imaging Stage With Pathologic Findings

International journal of radiation oncology, biology, physics, 2008-03, Vol.70 (4), p.1035-1038

2008

Volltextzugriff (PDF)

Reporting Late Rectal Toxicity in Prostate Cancer Patients Treated With Curative Radiation Treatment

International journal of radiation oncology, biology, physics, 2008-11, Vol.72 (3), p.777-781

2008

Volltextzugriff (PDF)

Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415

International journal of radiation oncology, biology, physics, 2023-05, Vol.116 (1), p.39-49

2023

Volltextzugriff (PDF)

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Radiotherapy and oncology, 2019-06, Vol.135, p.19-24

2019

Volltextzugriff (PDF)

Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy

Practical Radiation Oncology, 2019-01, Vol.9 (1), p.24-28

2019

Volltextzugriff (PDF)

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer

Radiation oncology (London, England), 2006-11, Vol.1 (1), p.42-42, Article 42

2006

Volltextzugriff (PDF)

Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes

Canadian journal of urology, 2016-04, Vol.23 (2), p.8209

2016

Volltextzugriff (PDF)

Ultrasound-based image guided radiotherapy for prostate cancer—comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy

International journal of radiation oncology, biology, physics, 2006-12, Vol.66 (5), p.1562-1567

2006

Volltextzugriff (PDF)

Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment

International Brazilian journal of urology, 2004-08, Vol.30 (4), p.289-295

2004

Volltextzugriff (PDF)

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer

International journal of radiation oncology, biology, physics, 2006-03, Vol.64 (3), p.842-848

2006

Volltextzugriff (PDF)

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy

Urology (Ridgewood, N.J.), 2006, Vol.67 (1), p.142-146

2006

Volltextzugriff (PDF)

Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG RTOG 0415

International journal of radiation oncology, biology, physics, 2023-02, Vol.116 (1), p.39-49

2023

Volltextzugriff (PDF)

Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?

American journal of clinical oncology, 2006-10, Vol.29 (5), p.463-467

2006

Volltextzugriff (PDF)

Abstract 2528: Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2528-2528

2021

Volltextzugriff (PDF)

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial RTOG 0415

Radiotherapy and oncology, 2019-03, Vol.135, p.19-24

2019

Volltextzugriff (PDF)

Radiotherapy in the treatment of vertebral hemangiomas

International journal of radiation oncology, biology, physics, 1985-02, Vol.11 (2), p.387-390

1985

Volltextzugriff (PDF)

B5-02: Radiotherapy volume delineation with PET in lung cancer may be less useful than foreseen

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S347-S347

2007

Volltextzugriff (PDF)

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer

International journal of radiation oncology, biology, physics, 2006-03, Vol.64 (3)

2006

Volltextzugriff (PDF)

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy

Urology (Ridgewood, N.J.), 2005, Vol.67 (1), p.142-146

2005

Volltextzugriff (PDF)

O uso de FDG-PET/TC scan no planejamento da radioterapia em câncer do pulmão não de pequenas células

Radiologia brasileira, 2007-10, Vol.40 (5), p.345-348

2007

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(81)
Humans
(59)
Technology
(54)
Engineering
(44)
Male
(36)
Physical Sciences
(34)
Chemistry
(27)
Female
(25)
Middle Aged
(24)
Oncology
(23)
Aged
(21)
Adult
(20)
Engineering, Chemical
(20)
Chemistry, Physical
(18)
Image Coding
(17)
Radiology, Nuclear Medicine & Medical Imaging
(16)
Biological And Medical Sciences
(15)
Engineering, Environmental
(15)
Patients
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer

Role of radiotherapy in metastatic non-small cell lung cancer

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

Impact of FDG-PET/CT on Radiotherapy Volume Delineation in Non–Small-Cell Lung Cancer and Correlation of Imaging Stage With Pathologic Findings

Reporting Late Rectal Toxicity in Prostate Cancer Patients Treated With Curative Radiation Treatment

Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy

Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer

Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes

Ultrasound-based image guided radiotherapy for prostate cancer—comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy

Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy

Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG RTOG 0415

Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?

Abstract 2528: Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415

MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial RTOG 0415

Radiotherapy in the treatment of vertebral hemangiomas

B5-02: Radiotherapy volume delineation with PET in lung cancer may be less useful than foreseen

Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer

No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy

O uso de FDG-PET/TC scan no planejamento da radioterapia em câncer do pulmão não de pequenas células

Suchergebnisse filtern